AAAAAA

   
Results: 1-24 |
Results: 24
PEGYLATED-LIPOSOMAL DOXORUBICIN VERSUS DOXORUBICIN, BLEOMYCIN, AND VINCRISTINE IN THE TREATMENT OF AIDS-RELATED KAPOSIS-SARCOMA - RESULTS OF A RANDOMIZED PHASE-III CLINICAL-TRIAL
Authors: NORTHFELT DW DEZUBE BJ THOMMES JA MILLER BJ FISCHL MA FRIEDMANKIEN A KAPLAN LD DUMOND C MAMELOK RD HENRY DH
Citation: Dw. Northfelt et al., PEGYLATED-LIPOSOMAL DOXORUBICIN VERSUS DOXORUBICIN, BLEOMYCIN, AND VINCRISTINE IN THE TREATMENT OF AIDS-RELATED KAPOSIS-SARCOMA - RESULTS OF A RANDOMIZED PHASE-III CLINICAL-TRIAL, Journal of clinical oncology, 16(7), 1998, pp. 2445-2451
FUMAGILLIN ANALOG IN THE TREATMENT OF KAPOSIS-SARCOMA - A PHASE-I AIDS CLINICAL-TRIAL GROUP-STUDY
Authors: DEZUBE BJ VONROENN JH HOLDENWILTSE J CHEUNG TW REMICK SC COOLEY TP MOORE J SOMMADOSSI JP SHRIVER SL SUCKOW CW GILL PS
Citation: Bj. Dezube et al., FUMAGILLIN ANALOG IN THE TREATMENT OF KAPOSIS-SARCOMA - A PHASE-I AIDS CLINICAL-TRIAL GROUP-STUDY, Journal of clinical oncology, 16(4), 1998, pp. 1444-1449
RANDOMIZED COMPARATIVE TRIAL OF PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS BLEOMYCIN AND VINCRISTINE IN THE TREATMENT OF AIDS-RELATED KAPOSIS-SARCOMA
Authors: STEWART S JABLONOWSKI H GOEBEL FD ARASTEH K SPITTLE M RIOS A ABOULAFIA D GALLESHAW J DEZUBE BJ
Citation: S. Stewart et al., RANDOMIZED COMPARATIVE TRIAL OF PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS BLEOMYCIN AND VINCRISTINE IN THE TREATMENT OF AIDS-RELATED KAPOSIS-SARCOMA, Journal of clinical oncology, 16(2), 1998, pp. 683-691
THE BIS-AZO COMPOUND FP-21399 INHIBITS HIV-1 REPLICATION BY PREVENTING VIRAL ENTRY
Authors: ZHANG JL CHOE H DEZUBE BJ FARZAN M SHARMA PL ZHOU XC CHEN LB ONO M GILLIES S WU YM SODROSKI JG CRUMPACKER CS
Citation: Jl. Zhang et al., THE BIS-AZO COMPOUND FP-21399 INHIBITS HIV-1 REPLICATION BY PREVENTING VIRAL ENTRY, Virology, 244(2), 1998, pp. 530-541
DRUGS THAT INHIBIT HERPESVIRUS DNA-SYNTHESIS BLOCK IN-VITRO ACTIVATION OF THE KAPOSIS-SARCOMA-ASSOCIATED HERPES-VIRUS (KSHV) IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS
Authors: SHANKAR P SERULNECK TM DEZUBE BJ LIEBERMAN J
Citation: P. Shankar et al., DRUGS THAT INHIBIT HERPESVIRUS DNA-SYNTHESIS BLOCK IN-VITRO ACTIVATION OF THE KAPOSIS-SARCOMA-ASSOCIATED HERPES-VIRUS (KSHV) IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 40-40
FUMAGILLIN ANALOG (TNP-470) IN THE TREATMENT OF KAPOSIS-SARCOMA - A PHASE-I AIDS CLINICAL-TRIAL GROUP-STUDY
Authors: DEZUBE BJ VONROENN JH HOLDENWILTSE J REMICK S COOLEY TP CHEUNG TW SOMMADOSSI JP SHRIVER SL SUCKOW CW GILL PS
Citation: Bj. Dezube et al., FUMAGILLIN ANALOG (TNP-470) IN THE TREATMENT OF KAPOSIS-SARCOMA - A PHASE-I AIDS CLINICAL-TRIAL GROUP-STUDY, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 78-78
TENIDAP INHIBITS REPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS-1 INCULTURED-CELLS
Authors: DEZUBE BJ AHLERS CM LAWRENCE JP TENG EI SILBERMAN SL PARDEE AB FINBERG RW
Citation: Bj. Dezube et al., TENIDAP INHIBITS REPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS-1 INCULTURED-CELLS, Journal of acquired immune deficiency syndromes and human retrovirology, 14(1), 1997, pp. 13-17
AIDS-RELATED KAPOSIS-SARCOMA
Authors: VANDENBRINK MRM DEZUBE BJ
Citation: Mrm. Vandenbrink et Bj. Dezube, AIDS-RELATED KAPOSIS-SARCOMA, Journal of clinical oncology, 15(3), 1997, pp. 1283-1284
EFFICACY OF PEGYLATED-LIPOSOMAL DOXORUBICIN IN THE TREATMENT OF AIDS-RELATED KAPOSIS-SARCOMA AFTER FAILURE OF STANDARD CHEMOTHERAPY
Authors: NORTHFELT DW DEZUBE BJ THOMMES JA LEVINE R VONROENN JH DOSIK GM RIOS A KROWN SE DUMOND C MAMELOK RD
Citation: Dw. Northfelt et al., EFFICACY OF PEGYLATED-LIPOSOMAL DOXORUBICIN IN THE TREATMENT OF AIDS-RELATED KAPOSIS-SARCOMA AFTER FAILURE OF STANDARD CHEMOTHERAPY, Journal of clinical oncology, 15(2), 1997, pp. 653-659
TOPOTECAN INHIBITS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION THROUGH A TOPOISOMERASE-INDEPENDENT MECHANISM IN A CELL-LINE WITH ALTERED TOPOISOMERASE-I
Authors: ZHANG JL SHARMA PL LI CJ DEZUBE BJ PARDEE AB CRUMPACKER CS
Citation: Jl. Zhang et al., TOPOTECAN INHIBITS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION THROUGH A TOPOISOMERASE-INDEPENDENT MECHANISM IN A CELL-LINE WITH ALTERED TOPOISOMERASE-I, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 977-981
LOW-DOSE COMPARED WITH STANDARD-DOSE M-BACOD CHEMOTHERAPY FOR NON-HODGKINS-LYMPHOMA ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: KAPLAN LD STRAUS DJ TESTA MA VONROENN J DEZUBE BJ COOLEY TP HERNDIER B NORTHFELT DW HUANG J TULPULE A LEVINE AM
Citation: Ld. Kaplan et al., LOW-DOSE COMPARED WITH STANDARD-DOSE M-BACOD CHEMOTHERAPY FOR NON-HODGKINS-LYMPHOMA ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The New England journal of medicine, 336(23), 1997, pp. 1641-1648
THE EFFECT OF TENIDAP ON CYTOKINES, ACUTE-PHASE PROTEINS, AND VIRUS LOAD IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-INFECTED PATIENTS - CORRELATION BETWEEN PLASMA HIV-1 RNA AND PROINFLAMMATORY CYTOKINE LEVELS
Authors: DEZUBE BJ LEDERMAN MM CHAPMAN B GEORGES DL DOGON AL MUDIDO P REISLISHING J CHENG SL SILBERMAN SL CRUMPACKER CS
Citation: Bj. Dezube et al., THE EFFECT OF TENIDAP ON CYTOKINES, ACUTE-PHASE PROTEINS, AND VIRUS LOAD IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-INFECTED PATIENTS - CORRELATION BETWEEN PLASMA HIV-1 RNA AND PROINFLAMMATORY CYTOKINE LEVELS, The Journal of infectious diseases, 176(3), 1997, pp. 807-810
CLINICAL PRESENTATION AND NATURAL-HISTORY OF AIDS-RELATED KAPOSIS-SARCOMA
Authors: DEZUBE BJ
Citation: Bj. Dezube, CLINICAL PRESENTATION AND NATURAL-HISTORY OF AIDS-RELATED KAPOSIS-SARCOMA, Hematology/oncology clinics of North America, 10(5), 1996, pp. 1023
THE KAPOSI SARCOMA-ASSOCIATED HERPESVIRUS (KSHV) IS PRESENT AS AN INTACT LATENT GENOME IN KS TISSUE BUT REPLICATES IN THE PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF KS PATIENTS
Authors: DECKER LL SHANKAR P KHAN G FREEMAN RB DEZUBE BJ LIEBERMAN J THORLEYLAWSON DA
Citation: Ll. Decker et al., THE KAPOSI SARCOMA-ASSOCIATED HERPESVIRUS (KSHV) IS PRESENT AS AN INTACT LATENT GENOME IN KS TISSUE BUT REPLICATES IN THE PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF KS PATIENTS, The Journal of experimental medicine, 184(1), 1996, pp. 283-288
DOSE-ESCALATION OF N,N',N''-TRIETHYLENETHIOPHOSPHORAMIDE COMBINED WITH PENTOXIFYLLINE FOR ADVANCED BREAST-CANCER
Authors: SHAPIRO CL DEZUBE BJ TRETYAKOV O WRIGHT J CAP B HENDERSON IC HAYES DF
Citation: Cl. Shapiro et al., DOSE-ESCALATION OF N,N',N''-TRIETHYLENETHIOPHOSPHORAMIDE COMBINED WITH PENTOXIFYLLINE FOR ADVANCED BREAST-CANCER, Clinical cancer research, 1(8), 1995, pp. 791-796
PENTOXIFYLLINE FOR THE TREATMENT OF HIV-INFECTION AND ITS COMPLICATIONS
Authors: DEZUBE BJ LEDERMAN MM
Citation: Bj. Dezube et Mm. Lederman, PENTOXIFYLLINE FOR THE TREATMENT OF HIV-INFECTION AND ITS COMPLICATIONS, Journal of cardiovascular pharmacology, 25, 1995, pp. 139-142
A TAT-INDUCED AUTO-UP-REGULATORY LOOP FOR SUPERACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROMOTER
Authors: BISWAS DK SALAS TR WANG FL AHLERS CM DEZUBE BJ PARDEE AB
Citation: Dk. Biswas et al., A TAT-INDUCED AUTO-UP-REGULATORY LOOP FOR SUPERACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROMOTER, Journal of virology, 69(12), 1995, pp. 7437-7444
HIGH-DOSE PENTOXIFYLLINE IN PATIENTS WITH AIDS - INHIBITION OF TUMOR-NECROSIS-FACTOR PRODUCTION
Authors: DEZUBE BJ LEDERMAN MM SPRITZLER JG CHAPMAN B KORVICK JA FLEXNER C DANDO S MATTIACCI MR AHLERS CM ZHANG L NOVICK WJ KASDAN P FAHEY JL PARDEE AB CRUMPACKER CS
Citation: Bj. Dezube et al., HIGH-DOSE PENTOXIFYLLINE IN PATIENTS WITH AIDS - INHIBITION OF TUMOR-NECROSIS-FACTOR PRODUCTION, The Journal of infectious diseases, 171(6), 1995, pp. 1628-1632
PENTOXIFYLLINE AND OTHER PROTEIN-KINASE-C INHIBITORS DOWN-REGULATE HIV-LTR NF-KAPPA-B INDUCED GENE-EXPRESSION
Authors: BISWAS DK AHLERS CM DEZUBE BJ PARDEE AB
Citation: Dk. Biswas et al., PENTOXIFYLLINE AND OTHER PROTEIN-KINASE-C INHIBITORS DOWN-REGULATE HIV-LTR NF-KAPPA-B INDUCED GENE-EXPRESSION, Molecular medicine, 1(1), 1994, pp. 31-43
PENTOXIFYLLINE FOR THE TREATMENT OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: DEZUBE BJ
Citation: Bj. Dezube, PENTOXIFYLLINE FOR THE TREATMENT OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 18(3), 1994, pp. 285-287
THE USE OF PENTOXIFYLLINE ALONE IN HIV-INFECTED PATIENTS - REPLY
Authors: DEZUBE BJ LEDERMAN MM
Citation: Bj. Dezube et Mm. Lederman, THE USE OF PENTOXIFYLLINE ALONE IN HIV-INFECTED PATIENTS - REPLY, Journal of acquired immune deficiency syndromes, 7(5), 1994, pp. 521-521
PENTOXIFYLLINE INHIBITS HIV-1 LTR-DRIVEN GENE-EXPRESSION BY BLOCKING NF-KAPPA-B ACTION
Authors: BISWAS DK DEZUBE BJ AHLERS CM PARDEE AB
Citation: Dk. Biswas et al., PENTOXIFYLLINE INHIBITS HIV-1 LTR-DRIVEN GENE-EXPRESSION BY BLOCKING NF-KAPPA-B ACTION, Journal of acquired immune deficiency syndromes, 6(7), 1993, pp. 778-786
PENTOXIFYLLINE DECREASES TUMOR-NECROSIS-FACTOR EXPRESSION AND SERUM TRIGLYCERIDES IN PEOPLE WITH AIDS
Authors: DEZUBE BJ PARDEE AB CHAPMAN B BECKETT LA KORVICK JA NOVICK WJ CHIURCO J KASDAN P AHLERS CM ECTO LT CRUMPACKER CS
Citation: Bj. Dezube et al., PENTOXIFYLLINE DECREASES TUMOR-NECROSIS-FACTOR EXPRESSION AND SERUM TRIGLYCERIDES IN PEOPLE WITH AIDS, Journal of acquired immune deficiency syndromes, 6(7), 1993, pp. 787-794
COOPERATIVE INHIBITION OF NF-KAPPA-B AND TAT-INDUCED SUPERACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT
Authors: BISWAS DK AHLERS CM DEZUBE BJ PARDEE AB
Citation: Dk. Biswas et al., COOPERATIVE INHIBITION OF NF-KAPPA-B AND TAT-INDUCED SUPERACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT, Proceedings of the National Academy of Sciences of the United Statesof America, 90(23), 1993, pp. 11044-11048
Risultati: 1-24 |